Maze Therapeutics to Participate in the 2023 Jefferies Healthcare Conf...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: October 2, 2023

How to Make a Difference This Halloween • Honouliuli National Historic Site Commemorated with Blessing Event and Plaque Dedication Ceremony • Afya Limited to Report Third Quarter and Nine Months 2023 Financial Results on November 13th • Global Gaming Women Announces Event Line-up at Global Gaming Expo 2023 including the 13th Annual Kick Up Your Heels Fundraiser • Essential Utilities Completes Sale of West Virginia Gas Utility Assets • iQor Celebrates Customer Service Week 2023 • Veteran Tech Exec Sissie Hsiao joins Bumble Inc. Board of Directors • Empire State Realty Trust Announces Acquisition of Prime Retail Asset in Williamsburg, Brooklyn, as Part of Capital Recycling Pr • Carmen M. Hernández Joins HITN’s Board of Directors • Link Logistics Publishes Third Annual ESG Report • U.S. Postal Service Commemorates Legacy of Ruth Bader Ginsburg • Most Women Skipping Annual Mammograms, According to New MedStar Health Survey • Simon® Earns GRESB Green Star • Feinstein Institutes’ Ross Prize awardees win 2023 Nobel Prize in Physiology or Medicine • BWX Technologies to Announce Third Quarter 2023 Results on Wednesday, November 1 • ComplyCube Unveils No-ID Age Estimation to Address Growing Global Age-Restriction Regulations • Remedios Varo Exhibition at Art Institute of Chicago Celebrates Hispanic Heritage Through Art • J&J Patent Move Must be First of Many, says AHF • EPA Names Clorox as 2023 Safer Choice Partner of the Year for Advancing Ingredient and Product Safety • Andreozzi + Foote File Lawsuits as the New Maryland Child Victims Law Takes Effect

Maze Therapeutics to Participate in the 2023 Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif. , June 01 /Businesswire/ - Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced that management will present a company overview at the 2023 Jefferies Healthcare Conference on Thursday, June 8, 2023, at 11:30 a.m. ET.

A live webcast of the presentation will be available here and in the news & press section of the company's website at www.mazetx.com. The webcast will be archived for 90 days following the presentation.

About Maze Therapeutics

Maze Therapeutics is a biopharmaceutical company that is harnessing the power of human genetics to transform the lives of patients, with a focus on genetically informed therapies for common diseases such as chronic kidney disease. Maze applies variant functionalization in tandem with advanced data science methods and a robust suite of research and development capabilities to advance a pipeline of novel precision medicines. Maze has developed the Maze Compass Platform^TM, a proprietary, purpose-built platform to understand and integrate the critical step of variant functionalization into each stage of drug development. Utilizing the Maze Compass Platform^TM, Maze is building a broad portfolio of wholly owned and partnered programs. Maze is based in South San Francisco. For more information, please visit mazetx.com, or follow us on LinkedIn and Twitter.